`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_________________
`
`PROLLENIUM US INC.,
`Petitioner,
`
`v.
`
`ALLERGAN INDUSTRIE, SAS,
`Patent Owner.
`
`_________________
`
`IPR2019-01505 (Patent 8,450,475 B2)
`IPR2019-01506 (Patent 8,357,795 B2)
`IPR2019-01508 (Patent 9,238,013 B2)
`IPR2019-01509 (Patent 9,358,322 B2)
`IPR2019-01617 (Patent 8,822,676 B2)
`IPR2019-01632 (Patent 8,357,795 B2)
`IPR2020-00084 (Patent 9,089,519 B2)
`_________________
`
`JOINT STIPULATION TO MODIFY DUE DATES 5 AND 6
` IN THE SCHEDULING ORDER1
`
`
`
`
`
`1 Authorization for the use of a joint caption page was received on April 27,
`
`2020. Neither party opposes the use of a joint caption page. An identical paper
`
`has been filed in each case recited in the consolidated caption.
`
`
`
`
`
`Prollenium US Inc. (“Petitioner”) and Allergan Industrie, SAS (“Patent
`
`Owner”), by and through their respective counsel of record, hereby stipulate as
`
`follows:
`
`
`
`On April 13, 2020, the Joint Scheduling Order in the Inter Partes Review of
`
`U.S. Patent No. 8,450,475 (IPR2019-01505), U.S. Patent No. 8,357,795 (IPR2019-
`
`01506), U.S. Patent No. 9,238,013 (IPR2019-01508), U.S. Patent No. 9,358,322
`
`(IPR2019-01509), U.S. Patent No. 8,822,676 (IPR2019-01617), U.S. Patent No.
`
`8,357,795 (IPR2019-01632), and U.S. Patent No. 9,089,519 (IPR2020-00084) set
`
`forth “due dates for the parties to take action in this trial,” and further stated that
`
`the “parties may stipulate different dates for DUE DATES 1, 2, 5, and 6, as well as
`
`the portion of DUE DATE 3 related to Patent Owner’s sur-reply (earlier or later,
`
`but no later than DUE DATE 7).” Id. at 7.
`
`
`
`Patent Owner and Petitioner hereby stipulate to modify DUE DATE 5 (nunc
`
`pro tunc) and the Petitioner’s portion of DUE DATE 6 as follows:
`
`
`
`
`
`
`
`
`
`DUE DATE 5:
`
`December 10, 2020
`
`Motions to Exclude Evidence
`
`DUE DATE 6, Petitioner only: December 17, 2020
`
`Petitioner’s Opposition to Motions to Exclude Evidence
`
`This stipulation does not affect or otherwise modify the remaining due dates
`
`in the Joint Scheduling Order.
`
`
`
`1
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Date: December 11, 2020
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Date: December 11, 2020
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`
`
`/Warren Thomas/
`Warren J. Thomas
`Reg. No. 70,581
`Petitioner, Prollenium US Inc.
`
`
`
`
`
`
`
`
`
`
`
`/Anthony M. Insogna/
`Anthony M. Insogna
`Reg. No. 35,203
`Patent Owner, Allergan Industrie, SAS
`
`
`
`
`
`2
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that I caused to be served on the
`
`counsel for Petitioner a true and correct copy of this JOINT STIPULATION TO
`
`MODIFY DUE DATES 5 AND 6 IN THE SCHEDULING ORDER by
`
`electronic means at the following address of record:
`
`mcc.prollenium.ipr@mcciplaw.com
`
`
`
`
`Dated: December 11, 2020
`
`
`
`
`
`
`
`
`
`/Anthony M. Insogna/
`Anthony M. Insogna (Reg. No. 35,203)
`JONES DAY
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121
`Telephone: 858-314-1200
`Fax: 844-345-3178
`
`Attorney for Patent Owner Allergan
`Industrie, SAS
`
`
`